Army Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

SAB and DoD advance therapeutic drug candidate for Covid-19

SAB Biotherapeutics has won an expanded scope on its Rapid Response contract for its new therapeutic drug candidate to treat Covid-19 pandemic. Credit: SAB Biotherapeutics.



  • SAB
Close
Close
Close

Go Top